Cargando…
The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice
BACKGROUND: We previously showed that 1-methylnicotinamide (1-MNA) and its analog 1,4-dimethylpyridine (1,4-DMP) could inhibit the formation of lung metastases and enhance the efficacy of cyclophosphamide-based chemotherapy in the model of spontaneously metastasizing 4T1 mouse mammary gland tumors....
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341170/ https://www.ncbi.nlm.nih.gov/pubmed/28270133 http://dx.doi.org/10.1186/s12885-017-3161-4 |
_version_ | 1782512943035842560 |
---|---|
author | Denslow, Agnieszka Switalska, Marta Nowak, Marcin Maciejewska, Magdalena Chlopicki, Stefan Marcinek, Andrzej Gebicki, Jerzy Wietrzyk, Joanna |
author_facet | Denslow, Agnieszka Switalska, Marta Nowak, Marcin Maciejewska, Magdalena Chlopicki, Stefan Marcinek, Andrzej Gebicki, Jerzy Wietrzyk, Joanna |
author_sort | Denslow, Agnieszka |
collection | PubMed |
description | BACKGROUND: We previously showed that 1-methylnicotinamide (1-MNA) and its analog 1,4-dimethylpyridine (1,4-DMP) could inhibit the formation of lung metastases and enhance the efficacy of cyclophosphamide-based chemotherapy in the model of spontaneously metastasizing 4T1 mouse mammary gland tumors. In the present study, we aimed to investigate whether the previously observed activity of pyridine compounds pertains also to the prevention and the treatment of metastatic prostate tumors, in a combined chemotherapy with docetaxel. METHODS: Cancer-preventing activity of 1,4-DMP was studied in the model of prostate tumors spontaneously arising in C57BL/6-Tg (TRAMP)8247Ng/J (TRAMP) mice. The efficacy of the combined chemotherapy, comprising simultaneous use of 1,4-DMP and docetaxel, was evaluated in the orthotopic mouse model of human PC-3M-luc2 prostate cancer. The toxicity of the applied treatment was also determined. RESULTS: The development of prostate tumors in TRAMP mice remained unaffected after administration of 1,4-DMP. Similarly, no effect of 1,4-DMP was found on the growth of orthotopically transplanted PC-3M-luc2 tumors. However, when 1,4-DMP was administered along with docetaxel, it enhanced the anticancer activity of the chemotherapy. As a result, in PC-3M-luc2-bearing mice statistically significant inhibition of the tumor growth and lower metastases incidence were observed. The decreased metastatic yield is probably related to the diminished platelet activity observed in mice treated with combined therapeutic regimen. Finally, the combined treatment exhibited lowered side effects accompanying docetaxel administration. CONCLUSIONS: Results presented herein confirm previously published data on the anticancer activity of pyridine compounds and demonstrate that 1,4-DMP may be beneficially implemented into chemotherapy utilizing various cytotoxic agents, directed against multiple metastatic tumor types. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3161-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5341170 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53411702017-03-10 The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice Denslow, Agnieszka Switalska, Marta Nowak, Marcin Maciejewska, Magdalena Chlopicki, Stefan Marcinek, Andrzej Gebicki, Jerzy Wietrzyk, Joanna BMC Cancer Research Article BACKGROUND: We previously showed that 1-methylnicotinamide (1-MNA) and its analog 1,4-dimethylpyridine (1,4-DMP) could inhibit the formation of lung metastases and enhance the efficacy of cyclophosphamide-based chemotherapy in the model of spontaneously metastasizing 4T1 mouse mammary gland tumors. In the present study, we aimed to investigate whether the previously observed activity of pyridine compounds pertains also to the prevention and the treatment of metastatic prostate tumors, in a combined chemotherapy with docetaxel. METHODS: Cancer-preventing activity of 1,4-DMP was studied in the model of prostate tumors spontaneously arising in C57BL/6-Tg (TRAMP)8247Ng/J (TRAMP) mice. The efficacy of the combined chemotherapy, comprising simultaneous use of 1,4-DMP and docetaxel, was evaluated in the orthotopic mouse model of human PC-3M-luc2 prostate cancer. The toxicity of the applied treatment was also determined. RESULTS: The development of prostate tumors in TRAMP mice remained unaffected after administration of 1,4-DMP. Similarly, no effect of 1,4-DMP was found on the growth of orthotopically transplanted PC-3M-luc2 tumors. However, when 1,4-DMP was administered along with docetaxel, it enhanced the anticancer activity of the chemotherapy. As a result, in PC-3M-luc2-bearing mice statistically significant inhibition of the tumor growth and lower metastases incidence were observed. The decreased metastatic yield is probably related to the diminished platelet activity observed in mice treated with combined therapeutic regimen. Finally, the combined treatment exhibited lowered side effects accompanying docetaxel administration. CONCLUSIONS: Results presented herein confirm previously published data on the anticancer activity of pyridine compounds and demonstrate that 1,4-DMP may be beneficially implemented into chemotherapy utilizing various cytotoxic agents, directed against multiple metastatic tumor types. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3161-4) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-07 /pmc/articles/PMC5341170/ /pubmed/28270133 http://dx.doi.org/10.1186/s12885-017-3161-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Denslow, Agnieszka Switalska, Marta Nowak, Marcin Maciejewska, Magdalena Chlopicki, Stefan Marcinek, Andrzej Gebicki, Jerzy Wietrzyk, Joanna The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice |
title | The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice |
title_full | The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice |
title_fullStr | The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice |
title_full_unstemmed | The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice |
title_short | The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice |
title_sort | effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341170/ https://www.ncbi.nlm.nih.gov/pubmed/28270133 http://dx.doi.org/10.1186/s12885-017-3161-4 |
work_keys_str_mv | AT denslowagnieszka theeffectsof14dimethylpyridineinmetastaticprostatecancerinmice AT switalskamarta theeffectsof14dimethylpyridineinmetastaticprostatecancerinmice AT nowakmarcin theeffectsof14dimethylpyridineinmetastaticprostatecancerinmice AT maciejewskamagdalena theeffectsof14dimethylpyridineinmetastaticprostatecancerinmice AT chlopickistefan theeffectsof14dimethylpyridineinmetastaticprostatecancerinmice AT marcinekandrzej theeffectsof14dimethylpyridineinmetastaticprostatecancerinmice AT gebickijerzy theeffectsof14dimethylpyridineinmetastaticprostatecancerinmice AT wietrzykjoanna theeffectsof14dimethylpyridineinmetastaticprostatecancerinmice AT denslowagnieszka effectsof14dimethylpyridineinmetastaticprostatecancerinmice AT switalskamarta effectsof14dimethylpyridineinmetastaticprostatecancerinmice AT nowakmarcin effectsof14dimethylpyridineinmetastaticprostatecancerinmice AT maciejewskamagdalena effectsof14dimethylpyridineinmetastaticprostatecancerinmice AT chlopickistefan effectsof14dimethylpyridineinmetastaticprostatecancerinmice AT marcinekandrzej effectsof14dimethylpyridineinmetastaticprostatecancerinmice AT gebickijerzy effectsof14dimethylpyridineinmetastaticprostatecancerinmice AT wietrzykjoanna effectsof14dimethylpyridineinmetastaticprostatecancerinmice |